In an effort to increase the number of university-affiliated companies receiving Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants, UI Ventures helped support an SBIR/STTR workshop hosted by Jordan Hobfall of the Iowa Innovation Corporation on Feb. 8.
Two University of Iowa spinout ventures received $25,000 in grants from the State of Iowa. These Proof of Commercial Relevance grants (POCR) will be used for confirming earlier marketing analyses, product positioning, and pricing models. Immortagen is entering the personalized cancer treatment market for women's cancers. NatureMIRI will soon begin market microRNAs for the research market.